RATIO-MORPHINE SR
ATC Code
N02AA01
Warning
Dear Health Care Professional,
ratiopharm inc., in consultation with Health Canada, is advising health care professionals of the immediate voluntary recall of a number of lots (see in attachment) of ratio-Morphine SR 15 mg, 30 mg and 60 mg tablets (DIN 02244790 – 02244791 – 02244792) due to the possibility that they may contain oversized tablets. The lots are being recalled as a precaution. The voluntary recall follows a report that tablets with as much as double the appropriate thickness were identified creating the possibility of taking double the dose prescribed.
If patients ingest oversized tablets they would be exposed to the potential risk of accidental overdose. The most important signs of overdose are respiratory depression, dizziness, confusion or extreme drowsiness. Serious overdosage may result in apnea, circulatory collapse, cardiac arrest and death.
No comments so far